CPA3 and chronic rhinosinusitis with nasal polyps: These results highlight potential regulatory mechanisms and therapeutic strategies involving CD109 and CPA3 in AR and CRSwNP, suggesting new avenues for targeted therapies and their associated regulatory networks.